The increase in survival among the oldest men is not statistically significant, and it concerns only a small minority of cases, but it may be that the very high survival attained in younger men has led to treatment of curative intent being offered to even the oldest men with testicular cancer.
However, the short survival attained in FOLFOX-treated patients with positive protein ERCC1 (HR, 1.91) (Kwon et al, 2007) or overexpression of ERCC1 mRNA (HR, 9.4) suggests that irinotecan or taxane-based regimens could be the better alternative for these patients.
The aim of this study is to evaluate the overall survival period attained by chemo-radiotherapy including interferon alpha 2b administration with adjuvant chemotherapy.
Accurate validation of associations between biomarkers and survival was attained using LOOCV discriminant analysis[ 40] that allows the assessment of the performance of biomarkers to classify individuals into high and low hazard (low and high survival, respectively).
While considerable progress in survival was attained by optimizing conventional interventions like chemotherapy, radiation, and bone marrow transplantation, it is now widely accepted that a therapeutic plateau has been reached.
Carcinoma of an unknown primary site (CUP) rank among the 10 most frequent cancers worldwide and its prognosis is notoriously poor with median survival rates attaining 8 months (Pavlidis and Fizazi, 2005).
There were 19 patients in the group which received only chemotherapy during remission; 7 of these patients remain alive (median survival after attaining remission 303 days) and only 5 are still in their first remission (median remission length 188 days).
Once the GLD fits to survival data is attained, other summary statistics such as hazards can be easily obtained and will be consistent with the same underlying survival distribution and the distributional shape of survival times can be easily gleaned by plotting the fitted GLD.
We and others have shown that sustained remissions resulting in better renal survival can be attained after treatment with plasma exchange [ 18, 19, 41].
Irinotecan and taxane-based regimens have been used in the treatment of advanced gastric cancer patients, with a similar survival to those attained with FOLFOX [ 30, 31].
As previously reported, longer survival was also attained by patients with high levels of BRCA1 (28.6 months; 95% CI, 20.2 36.9 months) compared with those with low levels (9.8 months; 95% CI, 7.2 12.5 months; P<0.0001; Wei et al, 2011).
